View in EDS HTML Full Text PDF Full Text

Effects of a pro‐resolving drug in COVID‐19: preclinical studies to a randomized, placebo‐controlled, phase Ib/IIa trial in hospitalized patients.

Saved in:
Bibliographic Details
Title: Effects of a pro‐resolving drug in COVID‐19: preclinical studies to a randomized, placebo‐controlled, phase Ib/IIa trial in hospitalized patients.
Authors: Almeida, Pedro R. J.1 (AUTHOR), Periard, Alexandre M.1 (AUTHOR), Tana, Fernanda L.1 (AUTHOR), Avila, Renata E.2 (AUTHOR), Milhorato, Larissa B.1 (AUTHOR), Alcantara, Katlen M. M.1 (AUTHOR), Resende, Carolina B.1 (AUTHOR), Serufo, Angela V.1 (AUTHOR), Santos, Felipe R.1 (AUTHOR), Teixeira, Danielle C.1 (AUTHOR), Queiroz‐Junior, Celso M.1 (AUTHOR), Fonseca, Talita C. M.1 (AUTHOR), Silva, Barbara L. V.1 (AUTHOR), Costa, Vivian V.1 (AUTHOR), Souza, Renan P.3 (AUTHOR), Perretti, Mauro4 (AUTHOR), Jonassen, Thomas E. N.5 (AUTHOR), Teixeira, Mauro M.1,6 (AUTHOR) mmtex.ufmg@gmail.com
Source: British Journal of Pharmacology. Dec2024, Vol. 181 Issue 23, p4750-4765. 16p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:00071188
DOI:10.1111/bph.17322